The MolDX: BDX-XL2 L37031 A/B MAC LCD was revised.

Revision Date 11/8/2018

Changed the title of the LCD to BDX-XL2 and all Xpresys references to BDX-XL2. Removed “The test is ordered by a physician certified in the XL2 Certification and Training Registry (CTR), and

• The following information is recorded: all clinical risk factors to calculate the Mayo, VA, and Brock cancer risk predictors; PET result (if used), physician pre-test risk assessment, physician post-test lung nodule management recommendation, any subsequent procedures (non-invasive or invasive), and clinical diagnosis based on those procedures (i.e., benign or malignant)” from the Coverage Summary section

Added additional data collected by Biodesix information to the Analysis of Evidence section. Changed the Level of evidence strength from Limited to Moderate. Added reference #18.

Source: https://www.palmettogba.com/palmetto/MolDX.nsf/vMasterDID/B46KEN0425?opendocument